Weyerhaeuser Co: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Feb 16, 2024 and accepted by EDGAR at Feb 16, 2024, 16:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $7.67bn | us-gaap:Revenues |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $5.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $1.68bn | us-gaap:GrossProfit |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $7.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $1.19bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $280.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $98.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $839.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $1.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $1.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 732,222,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $1.43bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $1.22bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $131.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $1.16bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $2.31bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $16.98bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $788.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $6.75bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $5.07bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $10.24bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-016434. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.